TCL Archive Death On Saltz Regimen Prompt Groups To Suspend Accrual On Colon Cancer Trials. May 11, 2001
TCL Archive Rosenberg’s Latest Results: 22% Response Seen With LAK/IL-2, 13% With High Dose IL-2 Alone April 10, 1987